These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
413 related items for PubMed ID: 27975304
21. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Schulze A, Mills K, Weiss TS, Urban S. Hepatology; 2012 Feb; 55(2):373-83. PubMed ID: 21953491 [Abstract] [Full Text] [Related]
22. HBV culture and infectious systems. Hayes CN, Chayama K. Hepatol Int; 2016 Jul; 10(4):559-66. PubMed ID: 26935052 [Abstract] [Full Text] [Related]
23. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S. J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872 [Abstract] [Full Text] [Related]
24. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Li H, Zhuang Q, Wang Y, Zhang T, Zhao J, Zhang Y, Zhang J, Lin Y, Yuan Q, Xia N, Han J. Cell Mol Immunol; 2014 Mar; 11(2):175-83. PubMed ID: 24509445 [Abstract] [Full Text] [Related]
25. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells. König A, Yang J, Jo E, Park KHP, Kim H, Than TT, Song X, Qi X, Dai X, Park S, Shum D, Ryu WS, Kim JH, Yoon SK, Park JY, Ahn SH, Han KH, Gerlich WH, Windisch MP. J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792 [Abstract] [Full Text] [Related]
26. In Vitro Infection with Hepatitis B Virus Using Differentiated Human Serum Culture of Huh7.5-NTCP Cells without Requiring Dimethyl Sulfoxide. Le C, Sirajee R, Steenbergen R, Joyce MA, Addison WR, Tyrrell DL. Viruses; 2021 Jan 12; 13(1):. PubMed ID: 33445753 [Abstract] [Full Text] [Related]
30. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. Okuyama-Dobashi K, Kasai H, Tanaka T, Yamashita A, Yasumoto J, Chen W, Okamoto T, Maekawa S, Watashi K, Wakita T, Ryo A, Suzuki T, Matsuura Y, Enomoto N, Moriishi K. Sci Rep; 2015 Nov 23; 5():17047. PubMed ID: 26592202 [Abstract] [Full Text] [Related]
31. Live Cell Imaging Confocal Microscopy Analysis of HBV Myr-PreS1 Peptide Binding and Uptake in NTCP-GFP Expressing HepG2 Cells. König A, Glebe D. Methods Mol Biol; 2017 Nov 23; 1540():27-36. PubMed ID: 27975305 [Abstract] [Full Text] [Related]
32. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection. Ueda Y, Gu W, Dansako H, Nishitsuji H, Satoh S, Shimotohno K, Kato N. Biochem Biophys Res Commun; 2019 Jul 12; 515(1):156-162. PubMed ID: 31133379 [Abstract] [Full Text] [Related]
33. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry. Fu L, Hu H, Liu Y, Jing Z, Li W. Virology; 2017 May 12; 505():1-11. PubMed ID: 28213271 [Abstract] [Full Text] [Related]
34. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide. Nio Y, Akahori Y, Okamura H, Watashi K, Wakita T, Hijikata M. Biochem Biophys Res Commun; 2018 Jun 27; 501(3):820-825. PubMed ID: 29723527 [Abstract] [Full Text] [Related]
35. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor. Li J, Tong S. Clin Mol Hepatol; 2015 Sep 27; 21(3):193-9. PubMed ID: 26523264 [Abstract] [Full Text] [Related]
36. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency. Liu C, Xu G, Gao Z, Zhou Z, Guo G, Li D, Jing Z, Sui J, Li W. Virology; 2018 Sep 27; 522():168-176. PubMed ID: 30032030 [Abstract] [Full Text] [Related]
37. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. Elife; 2012 Nov 13; 3():. PubMed ID: 25409679 [Abstract] [Full Text] [Related]
38. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide. Kaneko M, Watashi K, Kamisuki S, Matsunaga H, Iwamoto M, Kawai F, Ohashi H, Tsukuda S, Shimura S, Suzuki R, Aizaki H, Sugiyama M, Park SY, Ito T, Ohtani N, Sugawara F, Tanaka Y, Mizokami M, Sureau C, Wakita T. J Virol; 2015 Dec 13; 89(23):11945-53. PubMed ID: 26378168 [Abstract] [Full Text] [Related]
39. Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP. Donkers JM, Zehnder B, van Westen GJP, Kwakkenbos MJ, IJzerman AP, Oude Elferink RPJ, Beuers U, Urban S, van de Graaf SFJ. Sci Rep; 2017 Nov 10; 7(1):15307. PubMed ID: 29127322 [Abstract] [Full Text] [Related]
40. hNTCP‑expressing primary pig hepatocytes are a valuable tool for investigating hepatitis B virus infection and antiviral drugs. Zhou M, Qin B, Deng XS, Zeng XL, Lu Y, Huang ZG, Wu CC, Mou LS. Mol Med Rep; 2019 Oct 10; 20(4):3820-3828. PubMed ID: 31485670 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]